نتایج جستجو برای: hematologic stem cell transplantation

تعداد نتایج: 1903173  

Journal: :international journal of hematology-oncology and stem cell research 0
vahid zamanzadeh phd, mscn, bscn (associate professor) nursing and midwifery faculty, tabriz university of medical sciences, tabriz, iran. leila valizadeh phd, mscn, bscn (assistant professor) nursing and midwifery faculty, tabriz university of medical sciences, tabriz, iran. leila sayadi phd candidate, mscn, bscn, student in nursing, students' research committee, nursing & midwifery faculty, tabriz university of medical sciences, tabriz, iran. fariba taleghani phd, mscn, bscn (associate professor) nursing and midwifery care research center, nursing and midwifery faculty, isfahan university of medical sciences, isfahan, iran. alireza jeddian phd, md, hematology-oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran.

background: this study explored the state of hematopoietic stem cell transplantation (hsct) recipient patients and problems experienced by them and nurse about these state and problems, in iran. methods: qualitative content analysis was used for analyzing semi-structured interviews with 12 hsct recipient patients and 18 nurses. results: three main categories described the hsct state and problem...

Journal: :iranian journal of blood and cancer 0

hematopoietic stem cell transplantation (hsct) has been practiced for more than 30 years. hematological malignanciesare the main indications for this treatment. however, its indications in adults are different from children.advances in chemotherapy and target therapy have improved treatment outcome of some of the very high riskcancers, and changed indications of hsct in children. multi-center c...

Journal: :the journal of tehran university heart center 0
mojtaba salarifar tehran heart center, medical sciences/university of tehran, tehran, iran. kamran ali moghaddam shariati hospital, medical sciences/university of tehran, tehran, iran. seyed ebrahim kassaian tehran heart center, medical sciences/university of tehran, tehran, iran. mohammad alidoosti tehran heart center, medical sciences/university of tehran, tehran, iran. ali mohammad haji zeinali tehran heart center, medical sciences/university of tehran, tehran, iran. hakimeh sadeghian tehran heart center, medical sciences/university of tehran, tehran, iran.

background: early clinical investigations indicate that an infusion of autologous bone-marrow cells into the infarct-related coronary artery is feasible after acute myocardial infarction. there is increasing evidence that cell transplantation may improve the perfusion and contractile function of the ischemic myocardium . the present study reports primarily the safety of intracoronary bone marro...

Journal: :international journal of hematology-oncology and stem cell research 0
amir ali hamidieh hematology- oncology and stem cell transplantation research center, tehran university of medical sciences, dr. shariati hospital, tehran, iran kamran alimoghaddam hematology- oncology and stem cell transplantation research center, tehran university of medical sciences, dr. shariati hospital, tehran, iran mohammad jahani hematology- oncology and stem cell transplantation research center, tehran university of medical sciences, dr. shariati hospital, tehran, iran arash jalali hematology- oncology and stem cell transplantation research center, tehran university of medical sciences, dr. shariati hospital, tehran, iran afsaneh alimohammadi hematology- oncology and stem cell transplantation research center, tehran university of medical sciences, dr. shariati hospital, tehran, iran ardeshir ghavamzadeh hematology- oncology and stem cell transplantation research center, tehran university of medical sciences, dr. shariati hospital, tehran, iran

introduction: neuroblastoma is the most common extracranial solid tumor in children, accounting for 8% to 10% of all childhood cancers. significantly, autologous transplantation appeared to have the largest impact on survival for the high risk subset of patients, such as those with n-myc amplified metastatic disease diagnosed after age 2 years. patients and methods: this study includes high ris...

Journal: :international journal of hematology-oncology and stem cell research 0
saeed mohammadi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran ashraf malek mohammadi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran mohsen nikbakht hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran amir hossein norooznezhad hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran kamran alimoghaddam hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran ardeshir ghavamzadeh hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran

peripheral blood stem cell transplantation (pbsct) is an effective treatment for hematological malignancies. mobilization of peripheral blood progenitor cells performs in different ways among transplantation centers. forceful mobilization schedules are comprised of growth factor alone, chemotherapy along with growth factor and also, a newly combination of novel agent such as plerixafor with any...

Journal: :مجله بین المللی علوم آزمایشگاهی 0
kaveh tari arezou rahimi amir atashi saeid abroun mohammad shahjahani ali jalili

hematopoietic stem/progenitor cells (hspcs) which give rise to different blood cell types are present within the bone marrow microenvironment, especially in flat bones such as skull, vertebrae, pelvis and chest. interacting factors such as stromal derived factor-1/cxcr4, very late antigen-4/vascular cell adhesion molecule-1, lymphocyte function-associated antigen-1/ intercellular adhesion molec...

Journal: :international journal of hematology-oncology and stem cell research 0
leila sayadi phd candidate, school of nursing and midwifery, tabriz university of medical sciences,tabriz, iran. fateme jafaraghaee phd candidate, school of nursing and midwifery, tehran university of medical sciences, tehran, iran. alireza jeddian md, hematology-oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran. mahboobe kafaei atrian msc, school of nursing and midwifery, kashan university of medical science, kashan, iran. azam akbari msc nursing, guilan university of medical sciences, school of nursing and midwifery, guilan, iran. farhood tootoonchian md, hematology-oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran.

background: today, hematopoietic stem cells transplantation (hsct) has been accepted as a therapeutic approach and is widely applied in many patients with disorders of hematopoietic systems or patients with malignancies. concomitant use of this therapeutic approach with long term chemotherapeutic procedures and hospitalization requires special care. this study was conducted to examine basic nee...

Journal: :avicenna journal of medical biotechnology 0

spermatogonia are the male germ line stem cells whose life long expansion is needed for permanent production of spermatozoa. the present study was designed to examine the effect of hcg treatment on germ cell proliferation following stem cell transplantation in mice. spermatogonial stem cells were isolated from neonatal mice testes and characterized by alkaline phosphatase, immunoreactivity and ...

2017
Saeed Mohammadi Amir Hossein Norooznezhad Ashraf Malek Mohammadi Hajar Nasiri Mohsen Nikbakht Najmaldin Saki Mohammad Vaezi Kamran Alimoghaddam Ardeshir Ghavamzadeh

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) has been considered as a valuable approach in treatment of numerous malignant and none malignant hematologic disorders. However, relapse and poor graft function (PGF) after allo-SCT remain to be controversial issues which may affect the transplantation outcome. Relevant articles were searched in MEDLINE database (2000-2016) using ke...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید